Donoso-Barraza, C., Díaz-Roblero, M., Sepúlveda, C., Villegas-Bravo, A., Soto-Alarcón, S. A., Durán-Castillo, D., Castillo, V., Bravo-Sagua, R., Troncoso, R. (2026). FKBP51 disrupts the insulin signaling pathway and impairs mitochondrial bioenergetics in HepG2 cells. Scientific Reports. https://doi.org/10.1038/s41598-026-40414-9